Diversified pharmaceutical company with divisions
for novel medicines and complex generics
Series B Funding completed (15 billion KRW)
Selected as Korea Drug Development Fund project by KDDF
Joint R&D technology transfer contract signed (Yonsei University Health System)NEWS
In-Licensing from Yonsei University Health System (ARDS, Pendred)
ARBM-201 funded by Korea Drug Development Fund
Obtained Corporate R&D Institute certifications
Registered as a venture company (Small and Medium Business Administration)
ARBORMED Pharmaceuticals Inc. subsidiary established
US Export Agreement (Icure)NEWS
ARBORMED founded
ARBORMED Co., Ltd.
· 7th fl., 12, Nonhyeon-ro 81-gil, Gangnam-gu, Seoul 06237 Korea
· R&D Center : Alpha Tower 202, Pangyoyeok-ro 180, Bundang-gu, Seongnam-si, Gyeonggi-do 13524 Korea
· ARBORMED Pharmaceuticals Inc. : 611 Gateway Boulevard Suite 120 San Francisco, California 94080 USA
TEL : 02-6953-1207 (ARBORMED) / 031-8039-6219 (R&D Center) / +1 650-861-1353 (ARBORMED Pharmaceuticals Inc.)
E-mail : sseong@arbormed.com
Copyright© ARBORMED All Rights Reserved.
